Satyanarayana Rachagani View Appointment Options Satyanarayana Rachagani Appointment Options Research & Select Publications Share Copy Link Email Link Print Page Facebook X Instagram LinkedIn Back Gmail Outlook Apple Mail Yahoo! Mail Appointment Options Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you. Request an Appointment Call Us Refer a Patient Research & Select Publications Characterization of a bronchoscopically induced transgenic lung cancer pig model for human translatability Characterization of a bronchoscopically induced transgenic lung cancer pig model for human translatability Authors: Joshi K, Suvilesh KN, Natesh NS, [...]one or more additional authors omitted Rachagani S Journal & Year: Lab Anim (NY) | 2026 Functional significance of the aryl hydrocarbon receptor in oncogenic signaling pathways Functional significance of the aryl hydrocarbon receptor in oncogenic signaling pathways Authors: Arciga BM, Katepalli A, Natesh NS, [...]one or more additional authors omitted Rachagani S Journal & Year: Carcinogenesis | 2025 Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition Authors: Nethi SK, Gunda V, Natesh NS, [...]one or more additional authors omitted Rachagani S Journal & Year: iScience | 2025 The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention Authors: Thulasinathan B, Suvilesh KN, Maram S, [...]one or more additional authors omitted Rachagani S Journal & Year: Gut Microbes | 2025 Characterization of A Bronchoscopically Induced Transgenic Lung Cancer Pig Model for Human Translatability Characterization of A Bronchoscopically Induced Transgenic Lung Cancer Pig Model for Human Translatability Authors: Kaifi J, Joshi K, Suvilesh K, [...]one or more additional authors omitted Rachagani S Journal & Year: Res Sq | 2025 Pulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors Pulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors Authors: Arciga BM, Walters DM, Kimchi ET, [...]one or more additional authors omitted Rachagani S, Kaifi JT Journal & Year: Cancer Lett | 2025 Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer Authors: White BM, Gunda V, Nethi SK, [...]one or more additional authors omitted Rachagani S Journal & Year: Regen Eng Transl Med | 2025 Characterization of A Bronchoscopically Induced Transgenic Lung Cancer Pig Model for Human Translatability Characterization of A Bronchoscopically Induced Transgenic Lung Cancer Pig Model for Human Translatability Authors: Joshi K, Suvilesh KN, Natesh NS, [...]one or more additional authors omitted Rachagani S Journal & Year: bioRxiv | 2024 Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non-Small Cell Lung Cancer Patient-Derived Tumor Organoids Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non-Small Cell Lung Cancer Patient-Derived Tumor Organoids Authors: Suvilesh KN, Manjunath Y, Nussbaum YI, [...]one or more additional authors omitted Rachagani S, Kaifi JT Journal & Year: Clin Cancer Res | 2024 Pigs: Large Animal Preclinical Cancer Models Pigs: Large Animal Preclinical Cancer Models Authors: Joshi K, Katam T, Hegde A, [...]one or more additional authors omitted Rachagani S Journal & Year: World J Oncol | 2024 Benefits and opportunities of the transgenic Oncopig cancer model Benefits and opportunities of the transgenic Oncopig cancer model Authors: Joshi K, Telugu BP, Prather RS, [...]one or more additional authors omitted Rachagani S Journal & Year: Trends Cancer | 2024